AbbVie
ABBV
ABBV
3,492 hedge funds and large institutions have $249B invested in AbbVie in 2024 Q3 according to their latest regulatory filings, with 242 funds opening new positions, 1,421 increasing their positions, 1,391 reducing their positions, and 70 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
4% more funds holding
Funds holding: 3,359 → 3,492 (+133)
2% more repeat investments, than reductions
Existing positions increased: 1,421 | Existing positions reduced: 1,391
0.23% more ownership
Funds ownership: 71.63% → 71.86% (+0.23%)
Holders
3,492
Holding in Top 10
210
Calls
$3.65B
Puts
$2.87B
Top Buyers
| 1 | +$964M | |
| 2 | +$835M | |
| 3 | +$388M | |
| 4 |
Morgan Stanley
New York
|
+$275M |
| 5 |
State Street
Boston,
Massachusetts
|
+$237M |
Top Sellers
| 1 | -$388M | |
| 2 | -$339M | |
| 3 | -$264M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$262M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$246M |